However , compared with ENBD group , more patients in No-ENBD group had levels greater than three times the normal limit ( > 540 U/L ) ( 11/48 vs 3/45 , P = 0.0285 ) , and more patients developed to PEP ( 7/48 vs 0/45 , P = 0.0250 ) .